TECH

Bio-Techne Corporation

Healthcare · $11.4B market cap

Verdict

Share price

$72.40

close of Oct 3, 2026

Fair value

$34.24

Sticker Price

Payback Price

$13.70

buy price

Overpriced

TECH is Overpriced: at $72.40 it trades 111% above its fair value of $34.24. Its buy price (Payback Price) is $13.70, 81% below today's price. Business quality is limited: only 1 of 5 key numbers clears the 10% bar.

How we valued it

Owner Earnings. Earnings grow slowly (under 7% a year), but cash flow is steady, so we value it on its cash flow instead of its earnings.

Business quality

1 of 5 clear the 10% bar. What are the Big Five?

Earnings per share growth3.0% a year✗
Equity per share growth9.3% a year✗
Sales growth10.7% a year✓
Free cash flow growth5.9% a year✗
Return on invested capital6.0%✗

Follow TECH

Get notified when it reaches its buy price of $13.70. Free.

Create a free account

Superinvestors

5 of the investors we track hold TECH. In Q2 2026, 3 trimmed. Who we track

Moves in Q2 2026

Trimmed: Wallace Weitz, Lee Ainslie, Henry Ellenbogen

Insider activity

Since Jul 23, 2026: no open-market purchases and 58 other filings (stock awards, tax withholding and similar). Why purchases matter

Other filings

Crouse Steven C.

President - Diag & Spatial Bi · 2026-08-17

Award

8,702 shares

Crouse Steven C.

President - Diag & Spatial Bi · 2026-08-17

Award

14,140 shares

Geist William

PRESIDENT, PROTEIN SCIENCES · 2026-08-17

Award

14,762 shares

Geist William

PRESIDENT, PROTEIN SCIENCES · 2026-08-17

Award

23,985 shares

Herr Amy E.

director · 2026-08-17

Award

1,381 shares

Show all 58 other filings

Hippel James

CFO · 2026-08-17

Award

22,438 shares

Hippel James

CFO · 2026-08-17

Award

36,459 shares

Kelderman Kim

Chief Executive Officer · 2026-08-17

Award

57,590 shares

Kelderman Kim

Chief Executive Officer · 2026-08-17

Award

93,582 shares

Bohnen Shane

SVP - General Counsel · 2026-08-17

Award

11,344 shares

Bohnen Shane

SVP - General Counsel · 2026-08-17

Award

18,432 shares

Herr Amy E.

director · 2026-08-15

Option exercise

118 shares

Herr Amy E.

director · 2026-08-15

Option exercise

160 shares

Herr Amy E.

director · 2026-08-15

Tax withholding

$15K

Herr Amy E.

director · 2026-08-15

Option exercise

311 shares

Crouse Steven C.

President - Diag & Spatial Bi · 2026-08-15

Option exercise

1,379 shares

Crouse Steven C.

President - Diag & Spatial Bi · 2026-08-15

Option exercise

1,868 shares

Crouse Steven C.

President - Diag & Spatial Bi · 2026-08-15

Option exercise

2,176 shares

Crouse Steven C.

President - Diag & Spatial Bi · 2026-08-15

Tax withholding

$141K

Crouse Steven C.

President - Diag & Spatial Bi · 2026-08-15

Option exercise

5,423 shares

Bohnen Shane

SVP - General Counsel · 2026-08-15

Option exercise

49 shares

Bohnen Shane

SVP - General Counsel · 2026-08-15

D-Return

4,502 shares

Bohnen Shane

SVP - General Counsel · 2026-08-15

D-Return

$1.0M

Bohnen Shane

SVP - General Counsel · 2026-08-15

Option exercise

1,669 shares

Bohnen Shane

SVP - General Counsel · 2026-08-15

Option exercise

300 shares

Bohnen Shane

SVP - General Counsel · 2026-08-15

Option exercise

2,332 shares

Bohnen Shane

SVP - General Counsel · 2026-08-15

Tax withholding

$97K

Bohnen Shane

SVP - General Counsel · 2026-08-15

Option exercise

4,350 shares

Geist William

PRESIDENT, PROTEIN SCIENCES · 2026-08-15

D-Return

8,507 shares

Geist William

PRESIDENT, PROTEIN SCIENCES · 2026-08-15

D-Return

$1.9M

Geist William

PRESIDENT, PROTEIN SCIENCES · 2026-08-15

Option exercise

2,623 shares

Geist William

PRESIDENT, PROTEIN SCIENCES · 2026-08-15

Option exercise

3,226 shares

Geist William

PRESIDENT, PROTEIN SCIENCES · 2026-08-15

Option exercise

567 shares

Geist William

PRESIDENT, PROTEIN SCIENCES · 2026-08-15

Tax withholding

$143K

Geist William

PRESIDENT, PROTEIN SCIENCES · 2026-08-15

Option exercise

6,416 shares

Hippel James

CFO · 2026-08-15

D-Return

12,999 shares

Hippel James

CFO · 2026-08-15

D-Return

$3.0M

Hippel James

CFO · 2026-08-15

Option exercise

4,010 shares

Hippel James

CFO · 2026-08-15

Option exercise

4,903 shares

Hippel James

CFO · 2026-08-15

Option exercise

866 shares

Hippel James

CFO · 2026-08-15

Tax withholding

$312K

Hippel James

CFO · 2026-08-15

Option exercise

9,779 shares

Kelderman Kim

Chief Executive Officer · 2026-08-15

D-Return

8,835 shares

Kelderman Kim

Chief Executive Officer · 2026-08-15

D-Return

$1.9M

Kelderman Kim

Chief Executive Officer · 2026-08-15

D-Return

$1.7M

Kelderman Kim

Chief Executive Officer · 2026-08-15

Option exercise

554 shares

Kelderman Kim

Chief Executive Officer · 2026-08-15

Option exercise

8,543 shares

Kelderman Kim

Chief Executive Officer · 2026-08-15

Option exercise

588 shares

Kelderman Kim

Chief Executive Officer · 2026-08-15

Option exercise

11,785 shares

Kelderman Kim

Chief Executive Officer · 2026-08-15

Tax withholding

$783K

Kelderman Kim

Chief Executive Officer · 2026-08-15

Option exercise

21,470 shares

Herr Amy E.

director · 2026-08-15

Option exercise

589 shares

Hippel James

CFO · 2026-07-29

Tax withholding

$3.7M

Hippel James

CFO · 2026-07-29

Option exercise

$3.0M

Kelderman Kim

Chief Executive Officer · 2026-07-28

Tax withholding

$2.1M

Kelderman Kim

Chief Executive Officer · 2026-07-28

Option exercise

$1.7M

Bohnen Shane

SVP - General Counsel · 2026-07-23

Tax withholding

$25K

Bohnen Shane

SVP - General Counsel · 2026-07-23

Option exercise

$21K

About Bio-Techne Corporation

Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research, diagnostics, and bioprocessing markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Spatial Biology. The Protein Sciences segment develops and manufactures biological reagents used in various aspects of life science…

Biotechnology

Fair value and Payback Price are estimates from the company's reported financials, not investment advice. Prices as of the close of Oct 3, 2026. How the Payback Price works